Escitalopram efficacy on quality of life and prevention of depression in breast cancer patient with mastectomy
- Conditions
- Depression.Other mental disorders due to known physiological condition
- Registration Number
- IRCT20180421039376N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 75
Women 18-65 y/o
Diagnosed with breast cancer stage I,II,IIIa and undergone modified radical mostectomy with or without chemothrapy and radiotherapy
Consciously agreement
Having at least literacy of writing and reading
Pregnancy and lactation
History of conductive heart diseases
Severe renal failure
Moderate to severe hepatic failure
History of SSRI drugs reactions and sensitivity
Suffering from depression mood disorders, bipolar disorders or psychotic disorders based on DSM V criteria
Any condition limiting life expectancy
Any Use of anti depression or anti anxiety drugs since 2 weeks before the study
Any precipitation on group or individual psychotherapy sessions since 4 weeks before the study
Suffering from any speech disorders
Suffering from uncontrolled pain on the beginning of the study
Having suicide plans or thoughts on the beginning of the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depression. Timepoint: 0-4-8-12 week. Method of measurement: DASS questionnaire.
- Secondary Outcome Measures
Name Time Method